Verana Health Expands AI and Data Tools for Ophthalmology Research
Event summary
- Verana Health launched AI Agents and new datasets for ophthalmologic research ahead of AAO 2026.
- Collaboration with Bitfount integrates ophthalmic imaging and EHR data for clinical trial prescreening.
- New datasets include Retinal Vein Occlusion, Stargardt Disease, and variables for Glaucoma.
- Agent Claire provides conversational access to real-world patient data without programming skills.
- Verana Health will present research and services at AAO 2026 in New Orleans, October 9-12.
The big picture
Verana Health's enhancements align with the growing trend of leveraging real-world data and AI to drive clinical research and treatment optimization in ophthalmology. As the exclusive data partner of the American Academy of Ophthalmology's IRIS Registry, Verana Health is positioning itself as a key player in the digital transformation of ophthalmologic care. The company's focus on integrating imaging and EHR data underscores the industry's shift towards multimodal data resources for more comprehensive patient insights.
What we're watching
- AI Adoption
- How the integration of AI Agents will accelerate ophthalmologic research and treatment optimization.
- Data Expansion
- Whether Verana Health can sustain the pace of expanding its ophthalmic imaging initiative across community-based practices.
- Clinical Trial Efficiency
- The impact of the Bitfount collaboration on streamlining clinical trial prescreening and enrollment processes.
Related topics